FN1 and glioblastoma: We demonstrated that Dex injected in mice at doses equivalent to those used clinically to control brain tumor-related edema activates FNMA in GBM cells, resulting in the presence of a fibronectin barrier that contained the injected GBM cluster and significantly reduced the z-axis migration of tumor cells (Figure 3).